Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and generative models

24Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Salt-inducible kinase 2 (SIK2) has been recognized as a potential target for anti-inflammation and anti-cancer therapy. In this paper, based on the binding pose of the reported compound (GLPG-3970, 3) with AlphaFold protein structure, a series of hinge cores were generated via AI-generative models (Chemistry42). After the molecular docking, synthesis, and biological evaluation, a hit molecule (7f) targeting SIK2 was obtained with a novel scaffold. Further SAR exploration led to the discovery of compound 8g with superior potency against SIK2 compared with the reported inhibitors. Furthermore, 8g also demonstrated excellent selectivity over other AMPK kinases, favorable in vitro ADMET profiles and decent cellular activities. This work provides an alternative approach to the discovery of novel and selective kinase inhibitors.

Cite

CITATION STYLE

APA

Zhu, W., Liu, X., Li, Q., Gao, F., Liu, T., Chen, X., … Zhavoronkov, A. (2023). Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and generative models. Bioorganic and Medicinal Chemistry, 91. https://doi.org/10.1016/j.bmc.2023.117414

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free